Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Berdy

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Acta Ophthalmologica Scandinavica. Supplement|November 1, 2000
The effects of systemic medication on ocular allergic diseaseG J Berdy
Acta Ophthalmologica Scandinavica. Supplement|May 25, 1999
Atopic keratoconjunctivitis (AKC)G J Berdy
Allergy and Asthma Proceedings|November 4, 2000
Ocular allergic disease in the senior patient: diagnosis and managementG J Berdy
Acta Ophthalmologica Scandinavica. Supplement|November 1, 2000
Ocular allergic disorders and dry eye disease: associations, diagnostic dilemmas, and managementG J Berdy, B Hedqvist
Journal of Cataract and Refractive Surgery|September 1, 1989
Proper retrospective studyG J Berdy, C W Roberts
Clinical Therapeutics|September 18, 2001
Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge modelD L Spangler, G Bensch, G J Berdy
Archives of Internal Medicine|August 1, 1991
Angle closure glaucoma precipitated by aerosolized atropineG J Berdy, S S Berdy, L S Odin, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 1, 1992
Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effectsG J Berdy, M B Abelson, L M Smith, et al.
Clinical Therapeutics|August 17, 2000
A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge modelG J Berdy, D L Spangler, G Bensch, et al.
Journal of Ocular Pharmacology|January 1, 1991
Allergic conjunctivitis: a survey of new antihistaminesG J Berdy, M B Abelson, M A George, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Acta Ophthalmologica Scandinavica. Supplement|November 1, 2000
The effects of systemic medication on ocular allergic diseaseG J Berdy
Acta Ophthalmologica Scandinavica. Supplement|May 25, 1999
Atopic keratoconjunctivitis (AKC)G J Berdy
Allergy and Asthma Proceedings|November 4, 2000
Ocular allergic disease in the senior patient: diagnosis and managementG J Berdy
Acta Ophthalmologica Scandinavica. Supplement|November 1, 2000
Ocular allergic disorders and dry eye disease: associations, diagnostic dilemmas, and managementG J Berdy, B Hedqvist
Journal of Cataract and Refractive Surgery|September 1, 1989
Proper retrospective studyG J Berdy, C W Roberts
Clinical Therapeutics|September 18, 2001
Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge modelD L Spangler, G Bensch, G J Berdy
Archives of Internal Medicine|August 1, 1991
Angle closure glaucoma precipitated by aerosolized atropineG J Berdy, S S Berdy, L S Odin, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 1, 1992
Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effectsG J Berdy, M B Abelson, L M Smith, et al.
Clinical Therapeutics|August 17, 2000
A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge modelG J Berdy, D L Spangler, G Bensch, et al.
Journal of Ocular Pharmacology|January 1, 1991
Allergic conjunctivitis: a survey of new antihistaminesG J Berdy, M B Abelson, M A George, et al.
Pageof 1